Blocking tumor cell fatty acid metabolism by genetic overexpression of prolyl hydroxylase-3 (PHD3), an enzyme that normally represses fatty acid oxidation but is down-regulated in tumor cells from DIO mice, restored CD8+ TIL function and slowed tumor outgrowth. Here, EGLN3 is linked to neoplasm.